Home> Products> clinical response

{ "products": [ { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb194933ec7924333073c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PYRITIGMIN RIVA 1.5", "description": "Rivastigmine 1.5 mg capsule, marketed as PYRITIGMIN RIVA 1.5, is a prescription medication primarily used for the treatment of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of acetylcholine, a chemical messenger in the brain, to improve cognitive function, memory, and daily activities.\n\n \n\nComposition of Rivastigmine 1.5 mg Capsule\n \n\nActive Ingredient: Rivastigmine 1.5 mg\n\nBrand Name: PYRITIGMIN RIVA 1.5\n\nForm: Capsule\n\nCategory: Cholinesterase inhibitor\n\nManufacturer: Steris Healthcare\n\nEach capsule contains 1.5 mg of Rivastigmine, along with inactive excipients that help in capsule stability and absorption.\n\n \nWhat is Rivastigmine 1.5 mg?\n \n\nRivastigmine 1.5 mg is a central nervous system (CNS) acting drug used to treat cognitive decline in patients with Alzheimer’s and Parkinson’s disease dementia.\n\nIt inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine in the brain.\n\nBy increasing acetylcholine levels, it enhances communication between nerve cells, improving memory, attention, and problem-solving skills.\n\nPYRITIGMIN RIVA 1.5 is suitable for patients who require a low starting dose, helping to minimize side effects during treatment initiation.\n\n \nUses of Rivastigmine 1.5 mg Capsules\n \n\nTreatment of Mild to Moderate Alzheimer’s Disease\n\nImproves cognitive function, memory, and daily activity performance.\n\nManagement of Parkinson’s Disease Dementia\n\nHelps in improving memory, attention, and behavioral symptoms.\n\nSupportive Therapy for Cognitive Decline\n\nSlows the progression of dementia-related symptoms.\n\n \nDosage and Administration\n \n\nStarting Dose: 1.5 mg capsule twice daily (morning and evening) or as prescribed by a doctor.\nCapsules should be swallowed whole with water, preferably after meals to reduce gastrointestinal side effects.\n\nDose may be gradually increased based on tolerance and clinical response.\n\nRegular monitoring of weight, appetite, and cognitive function is recommended during therapy.\n\n \nBenefits of Rivastigmine 1.5 mg Capsules\n \n\nImproves memory and cognitive function\n\nEnhances daily living activities in dementia patients\n\nReduces behavioral and psychiatric symptoms associated with Alzheimer’s and Parkinson’s dementia\n\nProvides gradual symptom management with minimal side effects when initiated at low doses\n\nPYRITIGMIN RIVA 1.5 is patient-friendly due to its low starting dose\n\n \nSide Effects of Rivastigmine 1.5 mg Capsules\n \n\nWhile generally well-tolerated, some patients may experience mild to moderate side effects:\n\nNausea and vomiting\n\nLoss of appetite or weight loss\n\nDiarrhea\n\nDizziness or headache\n\nFatigue\n\nTremors\n\nSerious side effects (rare) include:\n\nSevere vomiting or dehydration\n\nAllergic reactions (rash, swelling, difficulty breathing)\n\nHeart rhythm changes (bradycardia)\n\nPatients should inform their doctor if any severe or persistent side effects occur.\n\n \nPrecautions Before Using Rivastigmine 1.5 mg\n \n\nInform your doctor if you have heart disease, liver problems, kidney disease, or stomach ulcers.\n\nUse with caution in patients prone to fainting or low blood pressure.\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a healthcare provider.\n\nAvoid sudden discontinuation of medication to prevent worsening of cognitive symptoms.\n\nMonitor for gastrointestinal issues and maintain hydration during therapy.\n\n \nDrug Interactions\n \n\nRivastigmine may interact with certain medications:\n\nCholinergic drugs (e.g., pilocarpine, bethanechol) – may increase cholinergic effects\n\nAnticholinergic drugs (e.g., atropine, scopolamine) – may reduce Rivastigmine’s effectiveness\n\nBeta-blockers or antiarrhythmics – may increase risk of slow heart rate\n\nNSAIDs or anticoagulants – monitor for gastrointestinal bleeding\n\nAlways inform your healthcare provider about all medications, supplements, and herbal products you are taking.\n\n \nConclusion\n \n\nRivastigmine 1.5 mg Capsules (PYRITIGMIN RIVA 1.5) are an effective treatment for cognitive decline associated with Alzheimer’s and Parkinson’s dementia.Always use Rivastigmine 1.5 mg under medical supervision, and follow prescribed dosage and lifestyle recommendations to achieve optimal cognitive support.", "price": 192.0, "discountamount": 58.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2176, "imageuri": "https://productimages.withfloats.com/actual/68beb197484e8a57b992d471.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb197484e8a57b992d471.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:36:04.37Z", "updatedon": "2025-09-08T10:36:04.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pyritigmin-riva-1-5/2176", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "rivastigmine 1.5 mg capsule", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68bc22e83c3803d861d696a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 200", "description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\n\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.", "price": 185.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2173, "imageuri": "https://productimages.withfloats.com/actual/68bc22f9fc1a4c6e66f328c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/68bc22f9fc1a4c6e66f328c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-06T12:02:48.098Z", "updatedon": "2025-09-08T10:03:20.923Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-200/2173", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cefpodoxime Proxetil Tablets IP 200 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6819e619af35b11ab7f87163", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BUDEPRESS FORTE 400 CAPSULES", "description": "BUDEPRESS FORTE 400 combines powerful inhalation therapy ingredients to manage asthma and chronic obstructive pulmonary disease (COPD). This medication contains Formoterol Fumarate (12 mcg) and Budesonide IP (400 mcg), working together to alleviate and prevent respiratory symptoms including wheezing, shortness of breath, chest constriction, and chronic coughing. It delivers both sustained control and quick symptom relief, enhancing lung function and life quality.\nActive Components:\nFormoterol Fumarate (12 mcg)\nA long-acting beta-2 adrenergic agonist (LABA) that delivers quick and extended bronchodilation by relaxing airway muscles. Effects begin within minutes and continue for up to 12 hours, making it excellent for ongoing therapy.\nBudesonide IP (400 mcg)\nA strong inhaled corticosteroid (ICS) that reduces lung inflammation, swelling, and mucus production—primary factors contributing to asthma and COPD symptoms.\nPrimary Advantages:\nCombination therapy featuring both bronchodilator and anti-inflammatory for comprehensive respiratory management.\nQuick relief from bronchial constriction and breathing difficulties.\nExtended symptom control lasting up to 12 hours with regular administration.\nReduces asthma attack frequency and COPD flare-up severity.\nEnhances respiratory function for easier, more comfortable breathing.\nRequires fewer daily doses compared to short-acting alternatives.\nAppropriate for moderate to severe respiratory conditions under medical guidance.\nMechanism of Action:\nBUDEPRESS FORTE 400 operates through complementary actions of its two key ingredients:\nFormoterol Fumarate eases bronchial tube smooth muscles, creating airway expansion and rapid relief from narrowing that causes breathing distress.\nBudesonide, as an anti-inflammatory steroid, addresses underlying airway inflammation causing chronic symptoms and exacerbations. It diminishes hyperresponsiveness and mucus accumulation with consistent use.\nTogether, they prevent airway tightening, decrease inflammation, and facilitate smooth airflow, offering better management of chronic respiratory conditions.\nUsage Instructions:\nUse only as prescribed by your healthcare provider.\nTypically administered twice daily (morning and evening), though dosage may vary based on condition severity and individual response.\nShake inhaler thoroughly before each use.\nRinse mouth completely with water after each use to avoid oral thrush (fungal infection).\nNever exceed the prescribed dosage.\nFor effective management, maintain consistent use even when symptoms improve.\nPotential Side Effects:\nMost patients tolerate BUDEPRESS FORTE 400 well, though side effects may occur:\nCommon Effects:\n\nVoice changes or hoarseness\nDry mouth or throat irritation\nCoughing or throat discomfort\nHeadache\nMild trembling or shakiness\nElevated heart rate (palpitations)\n\nLess Common but Serious Effects:\n\nOral or throat fungal infection (thrush)\nAllergic responses (rash, swelling, breathing difficulty)\nMuscle cramping\nChest discomfort\nWorsening respiratory issues (paradoxical bronchospasm)\n\nContact your physician immediately for persistent or severe side effects.\nImportant Precautions:\nNot for acute asthma attack treatment—always maintain a rescue inhaler for emergencies.\nInform your doctor about heart conditions, diabetes, thyroid disorders, or liver issues.\nAvoid exposure to contagious diseases (e.g., chickenpox, measles) while using corticosteroid therapy.\nPregnant or nursing women should consult healthcare providers before using.\nStore securely away from children.\nBUDEPRESS FORTE 400 provides a clinically validated, dual-action approach to respiratory comfort—combining immediate relief with long-term management. With proper medical supervision, it significantly improves daily activity levels and decreases respiratory symptom burden.", "price": 940.0, "discountamount": 282.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 hours", "prescribed dosage", "longterm management", "rapid relief", "12 hours making", "delivers quick", "manage asthma", "store securely", "nursing women", "chickenpox measles", "contagious diseases", "emergencies inform", "rescue inhaler", "physician immediately", "effects oral", "side effects", "condition severity", "vary based", "daily morning", "mucus accumulation", "diminishes hyperresponsiveness", "complementary actions", "shortacting alternatives", "extended bronchodilation", "sustained control", "wheezing shortness", "bronchial constriction", "chronic coughing", "respiratory comfortcombining", "throat irritation coughing", "breath chest constriction", "severe respiratory conditions", "prevent respiratory symptoms", "proper medical supervision", "consult healthcare providers", "corticosteroid therapy pregnant", "hoarseness dry mouth", "rinse mouth completely", "breathing distress budesonide", "medical guidance mechanism" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2101, "imageuri": "https://productimages.withfloats.com/actual/6819e61c974ab387c1d08df8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6819e61c974ab387c1d08df8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-06T10:36:09.795Z", "updatedon": "2025-05-06T10:36:09.795Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/budepress-forte-400-capsules/2101", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Formoterol Fumarate (12 mcg), Budesonide IP (400 mcg)", "category": "ASTHMARANGE", "tags": [ "Formoterol fumarate and budesonide powder for inhalation ip", "Formoterol fumarate and Budesonide powder for inhalation ip uses", "Formoterol fumarate and budesonide inhaler dosage", "Formoterol fumarate and Budesonide Powder for Inhalation IP 400" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d99766d075bc6e1b960947", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glycopyrrolate IP (Equivalent to Glycopyrronium 25mcg), In Isotonic solution 2ml", "description": "GLYCOPRESS \nGlycopyrrolate IP (Equivalent to Glycopyrronium 25mcg), In Isotonic solution 2ml\nGLYCOPRESS is a specialized pharmaceutical solution designed to effectively manage conditions involving excessive secretions in the body. This medication contains Glycopyrrolate IP, which is equivalent to Glycopyrronium 25mcg, and is presented in a 2ml isotonic solution. GLYCOPRESS is commonly used in clinical settings for patients requiring a reduction in bodily fluids, such as saliva or mucus, to improve comfort and manage symptoms related to various medical conditions.\n\nKey Benefits\nReduces Excessive Secretions: GLYCOPRESS effectively reduces saliva, mucus, and other bodily secretions, providing relief for patients with conditions like COPD and sialorrhea.\n\nEnhances Respiratory Function: By decreasing mucus production, GLYCOPRESS helps keep airways clear, which is particularly beneficial for patients with respiratory conditions.\n\nPreoperative Use: GLYCOPRESS is often administered before surgery to reduce secretions and maintain clear airways, lowering the risk of complications during procedures.\n\nConvenient Dosage Form: The 2ml isotonic solution ensures that the medication is easy to administer and is quickly absorbed by the body, providing fast relief.\n\nHow Does It Work?\nGLYCOPRESS works by blocking the action of acetylcholine, a neurotransmitter that stimulates glandular secretions in the body. By inhibiting acetylcholine's effects on muscarinic receptors, Glycopyrrolate reduces the production of fluids such as saliva, mucus, and stomach acid. This action makes GLYCOPRESS particularly useful in managing conditions where excessive secretions are problematic, such as in respiratory diseases or as a preparation for surgery.\n\nThe isotonic solution in which Glycopyrrolate is dissolved ensures that the medication is compatible with the body's natural fluids, facilitating smooth and effective administration, whether intravenously or intramuscularly.\n\nDirections for Use\nGLYCOPRESS is typically administered by a healthcare professional through intravenous or intramuscular injection. The dosage and frequency of administration depend on the specific condition being treated and the patient's response to the medication. It is important to follow the healthcare provider's instructions closely to ensure optimal effectiveness and minimize potential risks.\n\nFor COPD: Administer 1 ml (12.5 mcg) to 2 ml (25 mcg) twice daily, as recommended by a healthcare provider.\n\nFor Sialorrhea: Administer 1 ml (12.5 mcg) to 2 ml (25 mcg) once or twice daily, based on the severity of symptoms.\n\nFor Preoperative Use: A single dose of 2 ml (25 mcg) is typically given 30-60 minutes before surgery.\n\nSide Effects\nWhile GLYCOPRESS is generally well-tolerated, some patients may experience side effects. The most common side effects include:\n\nDry Mouth: A reduction in saliva production may lead to a dry mouth, which can be alleviated by drinking water or using saliva substitutes.\n\nBlurred Vision: Temporary blurred vision may occur, especially at higher doses.\n\nUrinary Retention: Some patients may find it difficult to urinate due to the anticholinergic effects of the medication.\n\nConstipation: By slowing gut motility, Glycopyrrolate can cause constipation, particularly with long-term use.\n\nIncreased Heart Rate: In rare instances, Glycopyrrolate may cause tachycardia (a fast heart rate), which should be monitored by a healthcare provider.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 2250.0, "discountamount": 675.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "2 ml", "1 ml", "25 mcg", "Dry Mouth", "single dose", "fast relief", "gut motility", "higher doses", "stomach acid", "Key Benefits", "clear airways", "long-term use", "bodily fluids", "natural fluids", "rare instances", "potential risks", "fast heart rate", "mucus production", "Preoperative Use", "saliva production", "Glycopyrrolate IP", "Urinary Retention", "clinical settings", "saliva substitutes", "specific condition", "healthcare provider", "common side effects", "respiratory diseases", "muscarinic receptors", "glandular secretions", "Respiratory Function", "excessive secretions", "Increased Heart Rate", "optimal effectiveness", "2ml isotonic solution", "Isotonic solution 2ml", "respiratory conditions", "Convenient Dosage Form", "anticholinergic effects", "intramuscular injection", "healthcare professional", "other bodily secretions", "effective administration", "Temporary blurred vision", "various medical conditions", "specialized pharmaceutical solution" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1970, "imageuri": "https://productimages.withfloats.com/actual/66d99795d84b3a29c4a85529.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d99795d84b3a29c4a85529.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:35:02.018Z", "updatedon": "2024-09-05T11:35:02.018Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glycopyrrolate-ip-equivalent-to-glycopyrronium-25mcg-in-isotonic-solution-2ml/1970", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLYCOPRESS ", "category": "ASTHMARANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e72553345171da8e569d1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX 250 ORAL SOLUTION ", "description": "DIOWELPREX 250 ORAL SOLUTION \nDivalproex (250mg/5ml)\nIntroduction\nDIOWELPREX 250 ORAL SOLUTION contains Divalproex (250mg/5ml), an anticonvulsant and mood-stabilizing medication used to treat various neurological and psychiatric conditions. It is particularly effective in managing epilepsy, bipolar disorder, and preventing migraine headaches.\n\nComposition\n\nDivalproex Sodium (250mg/5ml): A stable coordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship, providing a source of valproate ion which exhibits anticonvulsant and mood-stabilizing properties.\nMechanism of Action\nDivalproex works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps calm neuronal activity. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures, stabilizing mood in bipolar disorder, and preventing migraine headaches by altering the way nerves send signals.\n\nIndications\nDIOWELPREX 250 ORAL SOLUTION is indicated for:\n\nEpilepsy: Used to control various types of seizures including complex partial seizures and simple and complex absence seizures.\nBipolar Disorder: Helps in the management of manic episodes associated with bipolar disorder.\nMigraine Prophylaxis: Used to prevent migraine headaches.\nDosage and Administration\n\nEpilepsy: The initial dose is typically 10-15 mg/kg/day, gradually increased as needed and tolerated to achieve optimal clinical response.\nBipolar Disorder: The initial dose is generally 750 mg/day, given in divided doses, adjusted according to clinical response.\nMigraine Prophylaxis: The initial dose is usually 250 mg twice daily, adjusted as necessary.\nIt is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. The oral solution should be measured accurately using a dosing syringe or cup to ensure the correct dose is administered.\nSide Effects\nCommon side effects may include:\n\nNausea\nDrowsiness\nDizziness\nTremor\nHair loss\nWeight gain\nGastrointestinal disturbances\nMore severe side effects can include:\n\nLiver damage\nPancreatitis\nThrombocytopenia (low platelet count)\nHyperammonemia (high levels of ammonia in the blood)\nPrecautions\n\nLiver Function: Regular monitoring of liver function tests is recommended due to the risk of hepatotoxicity.\nPancreatitis: Patients should be monitored for signs of pancreatitis.\nPregnancy: Divalproex is associated with an increased risk of congenital malformations and should be used during pregnancy only if absolutely necessary and prescribed by a healthcare provider.\nBleeding Disorders: Caution is advised in patients with known bleeding disorders due to the risk of thrombocytopenia.\nDrug Interactions\n\nAntiepileptic Drugs: Concurrent use with other antiepileptic drugs may require dosage adjustments.\nWarfarin: May enhance the anticoagulant effect, necessitating close monitoring of INR levels.\nTopiramate: Co-administration can lead to hyperammonemia and encephalopathy.\nAlcohol: Should be avoided as it can exacerbate the side effects of Divalproex and further impair mental and motor skills.\nConclusion\nDIOWELPREX 250 ORAL SOLUTION is an effective medication for managing epilepsy, bipolar disorder, and preventing migraines. With its active ingredient Divalproex, it helps stabilize neuronal activity and mood. Proper dosage and administration under the guidance of a healthcare professional are essential to maximize benefits and minimize potential side effects. Regular monitoring and adherence to medical advice ensure the safe and effective use of DIOWELPREX 250 ORAL SOLUTION.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 445.0, "discountamount": 133.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "250 mg", "750 mg", "10-15 mg", "Hair loss", "INR levels", "high levels", "Weight gain", "motor skills", "correct dose", "initial dose", "Liver damage", "Proper dosage", "effective use", "divided doses", "various types", "valproate ion", "valproic acid", "increased risk", "medical advice", "Concurrent use", "dosing syringe", "manic episodes", "close monitoring", "sodium valproate", "bipolar disorder", "Divalproex Sodium", "active ingredient", "Drug Interactions", "neuronal activity", "dosage adjustments", "Bleeding Disorders", "Regular monitoring", "migraine headaches", "low platelet count", "healthcare provider", "electrical activity", "Common side effects", "effective medication", "anticoagulant effect", "Migraine Prophylaxis", "various neurological", "liver function tests", "1:1 molar relationship", "psychiatric conditions", "potential side effects", "healthcare professional", "gamma-aminobutyric acid", "congenital malformations", "complex absence seizures", "complex partial seizures", "More severe side effects", "other antiepileptic drugs", "optimal clinical response", "administration instructions", "inhibitory neurotransmitter", "mood-stabilizing properties", "mood-stabilizing medication", "DIOWELPREX 250 ORAL SOLUTION", "stable coordination compound", "Gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1933, "imageuri": "https://productimages.withfloats.com/actual/668e72573a68154e11e7951b.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e72573a68154e11e7951b.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:36:53.173Z", "updatedon": "2024-07-10T11:36:53.173Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-250-oral-solution-/1933", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX 250 ORAL SOLUTION ", "category": "NEUROLOGY RANGE", "tags": [ "Divalproex 250 mg", "Divalproex side effects", "Divalproex prolonged release tablets", "Divalproex extended release tablets IP 250 mg", "Divalproex prolonged release tablets uses", "Divalproex 250 mg side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666d687ab67e5121b02162fe", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "AZELIKEM 8 ", "description": "AZELIKEM 8 \nAzelnidipine (8mg)\nIntroduction:\n\nAZELIKEM 8 contains Azelnidipine, a calcium channel blocker used primarily for managing hypertension (high blood pressure). With a dosage strength of 8mg, AZELIKEM 8 helps in lowering blood pressure by relaxing blood vessels, thus improving blood flow and reducing the workload on the heart.\nKey Features and Benefits:\n\nBlood Pressure Control:\n\nVasodilation:\nAzelnidipine works by relaxing and widening blood vessels, which allows blood to flow more easily, thereby reducing blood pressure.\nLong-Lasting Effect:\nThe antihypertensive effect of Azelnidipine is sustained throughout the day, providing consistent blood pressure control.\nCardiovascular Health:\n\nReduced Cardiac Workload:\nBy lowering blood pressure, AZELIKEM 8 reduces the strain on the heart, which can help prevent complications such as heart attacks and strokes.\nImproved Circulation:\nEnhanced blood flow supports overall cardiovascular health, reducing the risk of cardiovascular events.\nPatient Tolerability:\n\nWell-Tolerated:\nAzelnidipine is generally well-tolerated with a favorable side effect profile, making it suitable for long-term use in managing hypertension.\nMinimal Side Effects:\nCommon side effects are mild and transient, including dizziness, headache, and flushing, which often diminish with continued use.\nDosage and Administration:\n\nRecommended Dosage:\n\nThe typical starting dose of AZELIKEM 8 for adults is one 8mg tablet taken once daily. The dose may be adjusted based on the patient's response and clinical condition.\nAdministration Instructions:\n\nOral Intake:\nAZELIKEM 8 tablets should be taken orally with water. They can be taken with or without food, but taking them at the same time each day helps maintain consistent blood levels.\nConsistency:\nFor optimal blood pressure control, it is important to take AZELIKEM 8 regularly as prescribed by your healthcare provider.\nContinued Monitoring:\n\nRegular monitoring of blood pressure and overall health is essential during AZELIKEM 8 therapy to ensure its efficacy and safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/azelikem-8-133260", "price": 99.0, "discountamount": 29.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "risk", "food", "EMAIL", "Order", "water", "strain", "safety", "adults", "strokes", "headache", "response", "efficacy", "Benefits", "dizziness", "same time", "information", "Consistency", "Oral Intake", "Vasodilation", "hypertension", "sterisonline", "Key Features", "Introduction", "sterispharma", "Azelnidipine", "complications", "long-term use", "blood vessels", "CALL/WHATSAPP", "heart attacks", "continued use", "overall health", "one 8mg tablet", "dosage strength", "Recommended Dosage", "AZELIKEM 8 tablets", "Regular monitoring", "AZELIKEM 8 therapy", "clinical condition", "high blood pressure", "Enhanced blood flow", "healthcare provider", "Long-Lasting Effect", "Common side effects", "Minimal Side Effects", "Improved Circulation", "Continued Monitoring", "Patient Tolerability", "typical starting dose", "cardiovascular events", "consistent blood levels", "calcium channel blocker", "antihypertensive effect", "Reduced Cardiac Workload", "Administration Instructions", "overall cardiovascular health", "favorable side effect profile", "optimal blood pressure control", "consistent blood pressure control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1914, "imageuri": "https://productimages.withfloats.com/actual/667d133b576e8da931df3ba1.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d133b576e8da931df3ba1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-15T10:10:02.777Z", "updatedon": "2024-06-29T12:18:51.24Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/azelikem-8-/1914", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "AZELIKEM 8 ", "category": "NEUROLOGY RANGE", "tags": [ "azelnidipine benefits", "Azelnidipine (8mg)", "azelnidipine 8 mg side effects", "azelnidipine and telmisartan tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c15c3d89239081848a6ac", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ZIPRANODE 40 ", "description": "ZIPRANODE 40 \nZiprasidone Capsules (40mg)\nIntroduction:\n\nZIPRANODE 40 contains Ziprasidone, an atypical antipsychotic medication, at a dosage strength of 40mg. It is designed for the treatment of schizophrenia and the manic or mixed episodes associated with bipolar disorder. ZIPRANODE 40 works by modulating the activity of neurotransmitters in the brain, helping to stabilize mood and reduce psychotic symptoms.\nKey Features and Benefits:\n\nAntipsychotic Action:\n\nZIPRANODE 40 is effective in treating the symptoms of schizophrenia, including hallucinations, delusions, thought disorders, and social withdrawal. It helps restore balance to neurotransmitters in the brain, particularly dopamine and serotonin.\nMood Stabilization:\n\nZiprasidone is also used to manage manic or mixed episodes in bipolar disorder. It helps control mood swings, reducing the intensity and frequency of manic episodes and helping patients maintain a stable mood.\nDual Mechanism of Action:\n\nZIPRANODE 40 acts as both a serotonin and dopamine receptor antagonist. This dual mechanism of action helps in effectively managing a broad range of symptoms associated with schizophrenia and bipolar disorder.\nFavorable Side Effect Profile:\n\nCompared to other antipsychotics, Ziprasidone has a lower risk of causing weight gain and metabolic disturbances, making it a preferred option for long-term management of psychiatric conditions.\nDosage and Administration:\n\nInitial Dosage for Schizophrenia:\n\nThe recommended starting dose of ZIPRANODE 40 for adults with schizophrenia is 20mg twice daily. The dose can be increased gradually based on the patient’s response and tolerability, up to a maximum of 80mg twice daily.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of manic or mixed episodes in bipolar disorder, the initial dose is 40mg twice daily. The dose can be adjusted based on clinical response, with a usual range of 40-80mg twice daily.\nAdministration Instructions:\n\nZIPRANODE 40 capsules should be taken orally with food to enhance absorption. Swallow the capsules whole with water. Do not crush or chew the capsules.\nContinued Monitoring:\n\nRegular monitoring of symptoms, side effects, and overall health is essential during ZIPRANODE 40 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/zipranode-40-133982", "price": 185.0, "discountamount": 55.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "80mg", "40mg", "food", "EMAIL", "water", "brain", "adults", "balance", "maximum", "activity", "patients", "Benefits", "serotonin", "intensity", "delusions", "treatment", "frequency", "absorption", "lower risk", "stable mood", "usual range", "broad range", "information", "weight gain", "mood swings", "initial dose", "sterisonline", "tolerability", "Key Features", "side effects", "sterispharma", "Introduction", "starting dose", "schizophrenia", "CALL/WHATSAPP", "hallucinations", "patient safety", "manic episodes", "overall health", "mixed episodes", "Dual Mechanism", "Initial Dosage", "dosage strength", "bipolar disorder", "thought disorders", "social withdrawal", "clinical response", "ZIPRANODE 40 acts", "neurotransmitters", "Mood Stabilization", "psychotic symptoms", "Regular monitoring", "Antipsychotic Action", "therapeutic efficacy", "ZIPRANODE 40 therapy", "Continued Monitoring", "long-term management", "Ziprasidone Capsules", "other antipsychotics", "ZIPRANODE 40 capsules", "psychiatric conditions", "metabolic disturbances", "Administration Instructions", "dopamine receptor antagonist", "Favorable Side Effect Profile", "atypical antipsychotic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1913, "imageuri": "https://productimages.withfloats.com/actual/667d1364c134db5b38ba45ba.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d1364c134db5b38ba45ba.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T10:04:51.679Z", "updatedon": "2024-06-29T12:17:40.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/zipranode-40-/1913", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ZIPRANODE 40 ", "category": "NEUROLOGY RANGE", "tags": [ "Ziprasidone Capsules (40mg)", "ZIPRANODE 40", "", "ziprasidone side effects", "ziprasidone warnings", "ziprasidone side effects weight loss", "ziprasidone mechanism of action" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c1007162db0236048bac5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 500 ", "description": "VALPOTREAT CR 500 \nSodium Valproate CR 500 mg\nIntroduction:\n\nVALPOTREAT CR 500 contains Sodium Valproate, a potent anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 500mg, VALPOTREAT CR 500 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 500 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 500 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 500 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 500 for adults typically starts at 500mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 500mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 500 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 500 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/valpotreat-cr-500-134217", "price": 121.18, "discountamount": 36.35, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "food", "time", "need", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "epilepsy", "severity", "patients", "Benefits", "frequency", "two doses", "adherence", "medication", "mood swings", "information", "initial dose", "GABA) levels", "tolerability", "sterispharma", "Key Features", "Introduction", "sterisonline", "various types", "CALL/WHATSAPP", "liver function", "Initial Dosage", "patient safety", "overall health", "manic episodes", "steady release", "mood stability", "mood stabilizer", "symptom control", "frequent dosing", "dosage strength", "seizure episodes", "absence seizures", "bipolar disorder", "treatment regimen", "clinical response", "neuronal activity", "Mood Stabilization", "Regular monitoring", "Sodium Valproate CR", "Continued Monitoring", "long-term management", "therapeutic efficacy", "Anticonvulsant Action", "potent anticonvulsant", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "favorable safety profile", "complex partial seizures", "typical maintenance dose", "VALPOTREAT CR 500 therapy", "VALPOTREAT CR 500 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1909, "imageuri": "https://productimages.withfloats.com/actual/666c100b8c6c791fd3b72fe4.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c100b8c6c791fd3b72fe4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:40:23.921Z", "updatedon": "2024-06-26T05:53:21.154Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-500-/1909", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 500 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 500 mg", "VALPOTREAT CR 500", "", "VALPOTREAT CR 500 price", "", "valprol cr 500 uses and side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }